As of December 31, 2024, the Company had cash, cash equivalents and marketable securities totaling $183.5 million.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LRMR:
- LRMR Earnings Report this Week: Is It a Buy, Ahead of Earnings?
- 3 Best Stocks to Buy Now, 1/30/2025, According to Top Analysts
- Apple downgraded, Rivian initiated: Wall Street’s top analyst calls
- Truist sees ‘significant upside’ for Larimar Therapeutics, starts with a Buy
- Larimar Therapeutics initiated with a Buy at Truist